QBFM
CLB icon

QS Batterymarch Financial Management’s Core Laboratories CLB Stock Holding History

QS Batterymarch Financial Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1.63M Sell
11,150
-5,650
-34% -$872K 0.04% 452
2014
Q2 		$2.81M Sell
16,800
-1,200
-7% -$213K 0.07% 382
2014
Q1 		$3.57M Sell
18,000
-450
-2% -$84.9K 0.07% 375
2013
Q4 		$3.52M Buy
18,450
+5,200
+39% +$968K 0.07% 382
2013
Q3 		$2.24M Sell
13,250
-36,150
-73% -$5.61M 0.05% 466
2013
Q2 		$7.49M Buy
+49,400
New +$7M 0.14% 188

Other funds holding CLB

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

QS Batterymarch Financial Management's CLB Position: Q3 2014 in Review

QS Batterymarch Financial Management reduced its Core Laboratories (CLB) stake by 34% in Q3 2014, selling an estimated $872K and leaving 11,150 shares worth $1.63M. The position accounts for 0.04% of the portfolio, ranked #452.

QS Batterymarch Financial Management first reported a position in CLB in Q2 2013 and has held it in 6 quarters since. The position peaked at $7.49M in Q2 2013. 344 funds tracked by Wall St. Rank hold CLB as of Q3 2014.

  • QS Batterymarch Financial Management held 11,150 shares of Core Laboratories worth $1.63M as of Q3 2014.
  • QS Batterymarch Financial Management sold 5,650 Core Laboratories shares in Q3 2014, an estimated $872K.
  • Core Laboratories made up 0.04% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #452 holding.
  • QS Batterymarch Financial Management first reported a position in Core Laboratories in Q2 2013 and has held it in 6 quarters since.
  • QS Batterymarch Financial Management's Core Laboratories position peaked at $7.49M in Q2 2013.
  • 344 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.